Bio Architecture Lab shifts ops, becomes CRO; Astellas signs up with Accenture for IT;

> Bio Architecture Lab is shifting its strategy from renewable chemicals and fuels and becoming a full-fledged CRO. News

> Industry group ACRO is launching a new video series in which leaders from various industries tout the importance of clinical research. Item

> Astellas Pharma ($ALPMY) has signed an 8-year outsourcing agreement with IT heavyweight Accenture. Article

> Sponsors and CROs are working toward a model that improves oversight without micromanaging. Report

> Accelrys ($ACCL) has extended its long-standing partnership with Pfizer ($PFE) to provide R&D software. Story

> Scale-up Systems and ScienView are teaming up to provide process-development software to China's biopharmaceutical industry. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.